Análise AI Multi-Horizonte
No intraday data supplied; daily volume below average suggests lack of conviction.
Price above 12-, 26-, and 50-day EMAs; MACD above signal line; RSI not overbought.
Revenue +92% YoY, operating margin improved 22 pp, cash and liquidity metrics sharply higher; offset by still-negative margins and sharply worse FCF.
Latest quarter shows 92% revenue growth, sharply narrower operating and net losses, and a much stronger balance sheet with $93.5B cash and 5.12 current ratio, but FCF worsened to -$25B and the company remains unprofitable.
Análise fundamental IA detalhada
Business Snapshot
- SPCX is listed as a NASDAQ common stock in U.S. dollars and is linked to Space Exploration Technologies Corp. The supplied sector and industry classifications are unavailable.
- The company was listed on June 12, 2026. Fundamental data therefore reflects a relatively limited reporting history in the payload.
- The stock closed at $136.97, after trading between $21.32 and $225.64 during the displayed daily history. Across 173 daily bars, it rose from $25.22 to $136.97, a 443.1% increase, indicating very high price volatility.
- No valuation multiples, analyst targets, earnings guidance, or forward estimates were provided.
Financial Trends
- Revenue: The latest reported revenue was $7.814 billion, up $3.743 billion, or 92.0%, from $4.071 billion in the comparable 2025-06-30 period. Only two income-statement periods are supplied, so a four-period quarterly revenue trajectory cannot be established.
- Operating profitability: Operating loss improved to $143 million from $970 million, a $827 million improvement. The operating margin improved from -23.83% to -1.83%, a 22.00 percentage-point improvement, showing substantial narrowing of operating losses but not yet positive operating income.
- Net profitability: Net loss improved to $541 million from $1.008 billion, a $467 million reduction. Net margin improved from -24.76% to -6.92%, a 17.84 percentage-point improvement. The company nevertheless remained unprofitable.
- Per-share results: Diluted EPS improved from -$0.34 to -$0.09. Diluted weighted-average shares increased from 2.929 billion to 5.864 billion, an increase of approximately 100.2%, which is relevant when assessing per-share progress.
- Free cash flow: Latest FCF was -$25.010 billion, compared with -$6.614 billion in the comparable 2025-06-30 period, a deterioration of $18.396 billion. The supplied data does not include a 2026-03-31 or 2025-12-31 FCF figure, so acceleration or deceleration across all four periods cannot be confirmed.
- Cash flow composition: Cash from operations increased from $351 million to $3.466 billion, a $3.115 billion improvement. However, investing cash outflow expanded from $6.032 billion to $34.487 billion, while capital expenditures rose from $6.965 billion to $28.476 billion. The result was sharply negative FCF despite stronger operating cash generation.
- Balance sheet: Total assets increased from $92.079 billion at 2025-12-31 to $192.770 billion at 2026-06-30, up $100.691 billion. Total liabilities increased from $50.754 billion to $65.546 billion, up $14.792 billion, while shareholders’ equity rose from $2.573 billion to $127.224 billion, up $124.651 billion. The 2026-03-31 and 2025-06-30 asset and liability fields are missing, limiting a complete four-period trajectory.
- Liquidity and leverage: Current ratio improved from 1.45 to 5.12, and working capital rose from $9.552 billion to $86.925 billion. Debt/equity declined from 8.54 to 0.29. These are major balance-sheet improvements, although the abrupt changes should be interpreted alongside the incomplete period data.
- Cash position: Cash and equivalents increased from $24.747 billion at 2025-12-31 to $93.522 billion at 2026-06-30, up $68.775 billion. Financing cash inflow was $100.291 billion, versus $9.199 billion in the comparable 2025 period, indicating that financing was a major contributor to the cash increase.
- Retained earnings: Retained earnings remained negative and worsened from -$37.035 billion to -$41.852 billion, a decline of $4.817 billion.
Financial Health
- The latest period shows a mixed but improving operating profile: revenue nearly doubled, operating and net losses narrowed materially, and operating cash flow improved.
- Liquidity and reported leverage strengthened substantially. The latest 5.12 current ratio, $93.522 billion cash balance, and 0.29 debt/equity indicate considerably more balance-sheet capacity than at 2025-12-31.
- The principal weakness is cash deployment. FCF deteriorated to -$25.010 billion, driven by a sharp increase in investing outflows and capital expenditures. Continued investment may support growth, but the payload does not provide guidance or returns data to determine whether those expenditures will generate adequate future profitability.
- The company is still loss-making, with a -1.83% operating margin and -6.92% net margin. Retained earnings remain deeply negative.
- The increase in diluted shares from 2.929 billion to 5.864 billion may reduce the benefit to each share from operational improvement. The data does not specify the cause of the increase.
- Overall, financial health has improved on liquidity, leverage, revenue growth, and loss reduction, but the trend is not yet a clean fundamental turnaround because profitability remains negative and FCF has worsened sharply.
Insider Activity
- Insider sentiment for 2026-05-25 through 2026-08-23 was Neutral (-10).
- Reported insider activity included $0 in purchases across three transactions and $1.200 billion in sales across nine transactions, for net selling of $1.200 billion.
- No Forms 4/5 insider filings were found for 2026-07-24 through 2026-08-23.
- The reported selling imbalance is a cautionary signal, but the payload does not identify the insiders, transaction types, or whether sales were automatic, tax-related, or discretionary. It should therefore be treated as context rather than a standalone trading signal.
Multi-Timeframe Technical Context
- Only the 1D timeframe is available. Minute- and hourly-based analysis for the ultra-short and short horizons cannot be confirmed from the supplied data.
- Ultra-short horizon — minutes: No 1-minute, 5-minute, or intraday indicator data is provided. The latest daily volume was 78.8 million, below the 20-day average of 118.7 million, suggesting the latest session was less active than its recent daily norm, but this does not establish an intraday direction.
- Short horizon — hours to days: Daily RSI-14 was 60.77 and RSI-21 was 57.43, indicating positive momentum without a classic overbought reading above 70. MACD was 4.697, above its 3.9714 signal line, which supports a bullish momentum bias.
- Price was above the 12-day EMA of $135.73, 26-day EMA of $131.03, and 50-day EMA of $119.33. This alignment is constructive, although the price remained below the 50-day SMA of $139.04, creating a nearby resistance test.
- The 20-day SMA/Bollinger middle band was $127.94. The upper Bollinger Band was $155.50, and the lower band was $100.39. At $136.97, price was above the middle band but below the upper band.
- Daily ATR was $10.80, implying a large typical daily price range relative to the current share price. This favors wider stops and highlights elevated short-term risk.
- Long horizon — weeks to months: The stock’s 173-bar gain of 443.1% establishes a powerful longer-term uptrend, but the move has also been highly volatile, with a displayed high of $225.64 and low of $21.32. The absence of weekly or monthly indicators limits confirmation of the longer-term trend structure.
Bull / Bear Cases
- Short-term bull case:
- Price is above the 12-, 26-, and 50-day EMAs.
- RSI remains constructive rather than technically overbought.
- MACD is above its signal line.
- A sustained move above the $139.04 50-day SMA could improve near-term momentum, with the $155.50 upper Bollinger Band as the next supplied technical reference.
- Short-term bear case:
- Price is below the recent displayed high of $225.64, and the stock’s large ATR indicates substantial downside volatility.
- A loss of the $127.94 middle Bollinger Band/20-day SMA would weaken the near-term setup.
- The latest volume was below its 20-day average, so the current move lacks confirmation from unusually strong participation.
- Net insider activity was heavily skewed toward selling.
- Long-term bull case:
- Revenue increased 92.0% year over year in the supplied periods.
- Operating and net margins improved materially, and diluted EPS loss narrowed from -$0.34 to -$0.09.
- Cash, working capital, current ratio, and debt/equity all improved sharply by the latest balance-sheet date.
- Operating cash flow turned substantially stronger, reaching $3.466 billion.
- Long-term bear case:
- The company remains unprofitable, with negative operating and net margins.
- FCF worsened to -$25.010 billion, while capital expenditures increased to $28.476 billion.
- The balance-sheet improvement coincided with $100.291 billion of financing cash inflow, so the cash increase was not solely generated by operations.
- Diluted shares approximately doubled, potentially diluting per-share value.
- Retained earnings remain negative and deteriorated by $4.817 billion from 2025-12-31.
- The stock’s 443.1% rise across 173 daily bars and broad $21.32-$225.64 range create significant valuation and volatility risk; no valuation data is available to assess whether the price reflects the improved fundamentals.
Key Levels & Triggers
- $139.04: 50-day SMA and immediate technical reference. A sustained break above could reinforce the short-term bullish setup.
- $155.50: Upper Bollinger Band and next upside technical reference after the 50-day SMA.
- $135.73 / $131.03: 12-day and 26-day EMAs, respectively; holding above them would preserve near-term momentum.
- $127.94: 20-day SMA and Bollinger middle band. A close below this level would weaken the current daily trend.
- $119.33: 50-day EMA and deeper trend support.
- $100.39: Lower Bollinger Band and major downside volatility reference.
- Fundamental triggers: Further revenue growth, continued narrowing of operating and net losses, conversion of operating cash flow into positive FCF, and evidence that elevated capital spending is producing improving profitability would strengthen the long-term thesis.
- Risk triggers: Renewed margin deterioration, continued expansion of negative FCF, additional share dilution, worsening retained earnings, or persistent insider selling would weaken the thesis.
- Because no intraday data, guidance, valuation, or analyst estimates were provided, minutes-to-hours triggers should be treated as provisional and confirmed against live price and volume action.